{"id":"W2612024030","doi":"10.1161/circulationaha.116.023940","title":"Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non–Vitamin K Antagonist Oral Anticoagulants Before Stroke","year":2017,"lang":"en","type":"article","venue":"Circulation","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"Daiichi Sankyo Europe; Janssen Pharmaceuticals; St. Jude Medical; Genentech; National Institutes of Health; Belvoir Media Group; AstraZeneca; Amarin Corporation; Duke Clinical Research Institute; Eisai; Boston VA Research Institute; Boston Scientific Corporation; Medicines Company; Regado Biosciences; American Stroke Association; Massachusetts General Hospital; GlaxoSmithKline; Eli Lilly and Company; Bristol-Myers Squibb; Amgen; Pfizer; H. Lundbeck A/S; Patient-Centered Outcomes Research Institute; Sanofi; American Heart Association","keywords":"Medicine; Warfarin; Rivaroxaban; Odds ratio; Dabigatran; Apixaban; Vitamin K antagonist; Stroke (engine); Confidence interval; Internal medicine; Anesthesia; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004598456,0.0002548771,0.0004810814,0.001005139,0.0004289679,0.0007473642,0.0003566424,0.000532567,0.001455807],"category_scores_gemma":[0.002277217,0.000321466,0.0006743252,0.001393995,0.0002904725,0.0006260495,0.0003876259,0.0009626921,0.0002417324],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004619611,"about_ca_system_score_gemma":0.000646413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004693043,"about_ca_topic_score_gemma":0.006445998,"domain_scores_codex":[0.9994918,0.00009964241,0.00009035391,0.00009908834,0.0001205562,0.00009855041],"domain_scores_gemma":[0.9978514,0.0002875765,0.001394502,0.00006870522,0.000110611,0.0002872618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00007632701,0.00002624079,0.9992693,0.000005114269,0.00002831387,0.00008101208,0.00001839541,0.0000200363,0.00003658423,0.000007467122,0.00006357522,0.000367559],"study_design_scores_gemma":[0.00001950099,0.0001179583,0.9988201,0.00001106282,0.00003596547,0.0005147043,0.0001200444,0.0001548068,0.00004525727,0.00003009048,0.0001259634,0.000004488664],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986863,0.0003146981,0.00003732162,0.00009251305,0.0000118414,0.000009796812,0.0003343892,0.000002172431,0.0005110491],"genre_scores_gemma":[0.9987696,0.0002570421,0.00007721028,0.00005852561,0.00003421483,0.00001219979,0.0006511453,0.000001549518,0.0001386423],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004693043,"threshold_uncertainty_score":0.009331405,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01883446098267582,"score_gpt":0.2583259987246246,"score_spread":0.2394915377419488,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}